References
- Steinman RM, Adans JC, Cohn ZA. Identification of a novel cell type in peripheral lymphoid organs of mice. IV. Identification and distribution in mouse spleen. J Exp Med 1975; 14: 804–20
- Shortman K, Naik SH. Steady-state and inflammatory dendritic-cell development. Nat Rev Immunol 2007; 7: 19–30
- Schnorrer P, Behrens GMN, Wilson NS, et al. The dominant role of CD8+ dendritic cells in cross-presentation is not dictated by antigen capture. PNAS 2006; 103: 10729–34
- Brown RD, Pope B, Murray A, et al. Dendritic cells from patients with myeloma are numerically normal but functionally defective as they fail to up-regulate CD80 (B7-1) expression after HuCD40LT stimulation because of inhibition by transforming growth factor-beta 1 and interleukin-10. Blood 2001; 98: 2992–8
- Wilkinson R, Kassianos AJ, Swindle P, et al. Numerical and functional assessment of blood dendritic cells in prostate cancer patients. Prostate 2006; 66: 180–92
- Radford KJ, Turtle CJ, Kassianos AJ, et al. The CMRF58 antibody recognizes a subset of CD123hi dendritic cells in allergen-challenged mucosa. J Leukoc Biol 2005; 77: 344–51
- Radford KJ, Turtle CJ, Kassianos AJ, Hart DN. CD11c+ blood dendritic cells induce antigen-specific cytotoxic T lymphocytes with similar efficiency compared to monocyte-derived dendritic cells despite higher levels of MHC class I expression. J Immunother 2006; 29: 596–605
- Ward KA, Stewart LA, Schwarer AP. CD34+-derived CD11c+ + +BDCA-1+ + CD123+ + DC: expansion of a phenotypically undescribed myeloid DC1 population for use in adoptive immunotherapy. Cytotherapy 2006; 8: 130–40
- Schnurr M, Chen Q, Shin A, et al. Tumor antigen processing and presentation depend critically on dendritic cell type and the mode of antigen delivery. Blood 2005; 105: 2465–72
- Luft T, Maraskovsky E, Schnurr M, et al. Tuning the volume of the immune response: strength and persistence of stimulation determine migration and cytokine secretion of dendritic cells. Blood 2004; 104: 1066–74
- Luft T, Rodionova E, Maraskovsky E , et al. Adaptive functional differentiation of dendritic cells: integrating the network of extra- and intracellular signals. Blood 2006;107(12):4763–9.
- Rodionova E, Conzelmann M, Maraskovsky E , et al. GSK-3 mediates differentiation and activation of pro-inflammatory dendritic cells. Blood 2007;109(4):1584–92.
- Sjolander A, Cox JC, Barr IG. ISCOMs: an adjuvant with multiple functions. J Leukoc Biol 1998; 64: 713–23
- Davis ID, Chen W, Jackson H, et al. Recombinant NY-ESO-1 protein with ISOMATRIX adjuvant induces broad integrated antibody and CD4+ and CD8+ T cell responses in humans. Proc Natl Acad Sci USA 2004; 101: 9363–8
- Boyle JS, Brady JL, Lew AM. Enhanced responses to a DNA vaccine encoding a fusion antigen that is directed to sites of immune induction. Nature 1998; 392: 408–11
- Deliyannis G, Boyle JS, Brady JL, et al. A fusion DNA vaccine that targets antigen-presenting cells increases protection from viral challenge. PNAS 2000; 97: 6766–80
- Corbett AJ, Caminschi I, McKenzie BS, et al. Antigen delivery via two molecules on the CD8– dendritic cell subset induces humoral immunity in the absence of conventional ‘danger’. Eur J Immunol 2005; 35: 2815–25
- Atlin JG, Parish CR. Liposomal vaccines: targeting delivery of antigen. Methods 2006; 40: 39–52
- Pinzon-Charry A, Schmidt C, Lopez JA. Dendritic cell immunotherapy for breast cancer. Expert Opin Biol Ther 2006;6(6):591–604.
- Pinzon-Charry A, Maxwell T, Lopez JA. Dendritic cell dysfunction in cancer: a mechanism for immunosuppression. Immunol Cell Biol 2005; 83: 451–61
- Pinzon-Charry A, Ho CSK, Laherty R, et al. A population of HLA-DR+ immature cells accumulates in the blood dendritic cell compartment of patients with different types of cancer. Neoplasia 2005; 7: 1112–22
- Davis I, Chen Q, Morris L, et al. Blood dendritic cells generated with Flt3 ligand and CD40 ligand prime CD8+ T cells efficiently in cancer patients. J Immunother 2006; 29: 499–511
- Radford KJ, Turtle CJ, Kassianos AJ, et al. Immunoselection of functional CMRF-56+ blood dendritic cells from multiple myeloma patients for immunotherapy. J Immunother 2005; 28: 322–31
- Morris ES, MacDonald KPA, Hill GR. Stem cell mobilisation with G-CSF analogs: a rational approach to separate GVHD and GVL. Blood 2006; 107: 3430–5
- Colin MP, Munster D, Clark G, et al. In vitro depletion of tissue-derived dendritic cells by CMRF-44 antibody and alemtuzumab: implications for the control of graft-versus-host disease. Transplantation 2005; 79: 722–5
- Lim WH, Kireta S, Thomson AW, et al. Renal transplantation reverses functional deficiencies in circulating dendritic cell subsets in chronic renal failure patients. Transplantation 2006; 81: 160–8
- Lim WH, Russ GR, Coates PT. Review of Epstein–Barr virus and post-transplant lymphoproliferative disorder post-solid organ transplantation. Nephrology 2006; 11: 355–66
- Lim WH, Kireta S, Russ GR, Coates PT. Human plasmacytoid dendritic cells regulate immune responses to Epstein–Barr virus (EBV) infection and delay EBV-related mortality in humanized NOD-SCID mice. Blood 2007; 109: 1043–50
- Thomas R. Viewpoint. The TRAF6-NFκB signaling pathway in autoimmunity: not just inflammation. Arthritis Res Ther 2005; 7: 170–3
- Cavanagh LL, Boyce A, Smith L, et al. Rheumatoid arthritis synovium contains plasmacytoid dendritic cells. Arthritis Res Ther 2005; 7: R230–40
- Moghaddami M, Mayrhofer G, Cleland LG. MHC Class II compartment, endocytosis and phagocytic activity of macrophages and putative dendritic cells isolated from normal tissues rich in synovium. Int Immunol 2005; 17(8)1117–30
- Moghaddami M, Cleland LG, Mayrhofer G. MHC II+ CD45+ cells from synovium-rich tissues of normal rats: phenotype, comparison with macrophage and dendritic cell lineages and differentation into many dendritic cells in vitro. Int Immunol 2005; 17(8)1103–15